MGLU2/3 ANTAGONISTS FOR THE TREATMENT OF INTELLECTUAL DISABILITIES

This invention relates to a new medical use for certain chemical compounds and pharmaceutical compositions containing them. The invention relates to compounds which are mGlu2/3 negative allosteric modulators for use in the treatment of intellectual disabilities. In another aspect, the invention rela...

Full description

Saved in:
Bibliographic Details
Main Authors Silvia Gatti MCARTHUR, Juergen WICHMANN, Theresa M. BALLARD, Thomas WOLTERING, Michael SAXE
Format Patent
LanguageEnglish
Spanish
Published 13.01.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention relates to a new medical use for certain chemical compounds and pharmaceutical compositions containing them. The invention relates to compounds which are mGlu2/3 negative allosteric modulators for use in the treatment of intellectual disabilities. In another aspect, the invention relates to a pharmaceutical composition for use in the treatment of intellectual disabilities comprising a compound according to the invention and a pharmaceutically acceptable carrier. Esta invención hace referencia a una nueva utilización médica de ciertos compuestos químicos y composiciones farmacológicas que los contienen. La invención hace referencia a compuestos que son moduladores alostéricos negativos de mGlu2/3 para su utilización en el tratamiento de varias discapacidades intelectuales. En otro aspecto, la invención hace referencia a una composición farmacológica para su utilización en el tratamiento de varias discapacidades intelectuales que incluye un compuesto de acuerdo con la invención y un transportador farmacológicarnente aceptable.
Bibliography:Application Number: MX20160013711